Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03899064 · ClinicalTrials.gov registry record · Phase 1
Evaluation of Potential Development of Photoallergic Skin Reaction After Use of MC2-01 Cream
A Phase 1 study, sponsored by MC2 Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 58
- Enrollment target
NCT03899064 is a Phase 1 study that has completed, run by MC2 Therapeutics. The registered enrollment target is 58 participants.
The verdict
NCT03899064, a Phase 1 study, has completed, sponsored by MC2 Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 58 participants
- Enrollment target
Study Summary
This trial is a 6-week, Randomized study evaluating the potential of MC2-01 Cream to induce a photoallergic skin reaction in Healthy subjects, using a controlled photopatch test design.
Interventions
- DRUG Induction: Application of MC2-01 Cream, irradiation
- DRUG Induction: Application of MC2-01 Cream, no irradiation
- DRUG Induction: Applications of MC2-01 vehicle, irradiation
- DRUG Induction: Applications of MC2-01 vehicle, no irradiation
- DRUG Challenge: Application of MC2-01 Cream, irradiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2019-02-13 |
| Est. Completion | 2019-04-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03899064
The ClinicalTrials.gov registry entry for NCT03899064 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MC2 Therapeutics, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Induction: Application of MC2-01 Cream, irradiation is the first listed.
NCT03899064 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03899064 about?
NCT03899064 is a clinical study titled "Evaluation of Potential Development of Photoallergic Skin Reaction After Use of MC2-01 Cream". This trial is a 6-week, Randomized study evaluating the potential of MC2-01 Cream to induce a photoallergic skin reaction in Healthy subjects, using a controlled photopatch test design.
What is the current status of trial NCT03899064?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 58 participants. The study started on 2019-02-13. Estimated completion is 2019-04-05.
What interventions are being tested in trial NCT03899064?
The interventions under investigation include: Induction: Application of MC2-01 Cream, irradiation (DRUG), Induction: Application of MC2-01 Cream, no irradiation (DRUG), Induction: Applications of MC2-01 vehicle, irradiation (DRUG), Induction: Applications of MC2-01 vehicle, no irradiation (DRUG), Challenge: Application of MC2-01 Cream, irradiation (DRUG).
Who is sponsoring clinical trial NCT03899064?
This trial is sponsored by MC2 Therapeutics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.